Mr. Speaker, I am pleased to take part in this debate which calls for a Canadian strategy for cancer control and mental health as well as tackling heart disease. These are all very important issues.
We have all been touched by cancer. I lost both of my parents to cancer about two years ago. They died very close in time to each other, one from stomach cancer and one from bowel cancer. Like most Canadians, I have been touched by cancer. I know the awful legacy that it leaves for families.
As a member of Parliament, I have had the chance to speak with a lot of people about it, people like Charlene Dill, who came to ask me to support funding for the strategy, and Barbara Thompson, who came to see me about the tremendous work that she is doing on breast cancer in Dartmouth—Cole Harbour. She has set up a support group for people who have breast cancer.
I want to talk a bit about the cardiovascular disease aspect of this motion. I was involved with the Heart and Stroke Foundation in Nova Scotia, both as president on the provincial board and on the national board for a number of years. Cardiovascular disease is the leading cause of death in Canada, accounting for at least 36% of all deaths, about 80,000 people a year. More than 450,000 Canadians are hospitalized for cardiovascular disease per year.
The most common problems are coronary artery disease, arrhythmia, valve disorders and heart muscle disease, including congestive heart failure. It is estimated that one in four Canadians or eight million people have some form of heart disease, disease of the blood vessels or are at risk for stroke. The economic cost is staggering, $18.4 billion a year.
In this regard, I would like to compliment the hon. member for putting forward this motion, which I know was done with the best of intentions for Canadians, and a motion that I will support. The hon. member knows, as a colleague of mine on the health committee, of my interest in promoting a national wellness strategy, a way to get at the illness of Canadians hopefully before it strikes them, but also to look at the issues of home care, palliative care and support for people who are sick.
Today I want to talk not only about cardiovascular disease but specifically about cardiovascular research which is such a key part of the work that the Government of Canada is doing to promote heart research and develop a national approach to fighting this disease.
Harnessing Canadian investments in health research is the key to improving the health of our citizens by building sustainable, evidence based, leading edge health care and public health systems, and developing the transformative new technologies of tomorrow. That is why the government created the CIHR, the Canadian Institutes of Health Research, in 2000.
Since that time, CIHR has led the transformation of the health research enterprise in Canada. Today CIHR is strengthening support for excellent research, expanding strategic research, training the next generation of health researchers, accelerating the transfer of knowledge into action, building capacity across Canada, attracting and retaining world class researchers and responding to emerging health threats.
With an annual budget of nearly $700 million, CIHR is Canada's lead funder of health research, supporting the work of 10,000 researchers in universities, teaching hospitals and other institutions. Of this total, CIHR invested more than $109 million in heart research last year. I am pleased to note that budget 2005 increased CIHR's budget by $32 million, a clear signal of our continued support for health research.
I should also note that along with the CIHR the government has announced investments of more than $13 billion for research and innovation since 1997. These have been extremely beneficial, creating the beginnings of an internationally competitive Canadian health research environment, something that we really needed.
The CIHR funding commitment to heart research is being leveraged through partnerships spearheaded by CIHR'S Institute of Circulatory and Respiratory Health, one of the CIHR's 13 vital institutes of health research. The institute, led by Dr. Bruce McManus, who is an international leader, supported by an advisory board comprising volunteers from all parts of the cardiovascular community, has been breaking new ground in developing a national heart research agenda for Canada.
Partnerships are integral to the vision of CIHR. By building partnerships among its stakeholders, those that have interest and a stake in health, the health system and health research, Canada will be better positioned to support stronger internationally competitive research initiatives that produce quality results more quickly for the benefit of Canadians.
CIHR partner organizations include other federal departments. They include provincial funding agencies and relevant provincial and territorial departments, health charities, non-government organizations and private industry.
Over the last several years the Institute of Circulatory and Respiratory Health has worked closely with its partners to develop its strategic plan and research initiatives. Much in the spirit of the motion that we are debating today, the institute's strategic plan builds on existing knowledge, fills gaps and maximizes Canadians' investment in health research by stressing cooperation and minimizing overlap.
A quick glance at the list of partners that the institute is working in conjunction with is very impressive. Among them are the Canadian Hypertension Society, Blood Pressure Canada, the Quebec Hypertension Society and the Heart and Stroke Foundation of Canada. I well recall being on the national board of the Heart and Stroke Foundation when CIHR was brought along and developed, replacing the old MRC. I can speak on behalf of the Heart and Stroke Foundation on how delighted we were with this incredible new funding agency, and the new avenues of research that had opened to the Heart and Stroke Foundation.
I want to talk about a couple of the returns on investment for which CIHR has been responsible. For example, Dr. Jafna Cox of Dalhousie who found that alternative medicines with prescription heart drugs can have deadly consequences for cardiac patients. Dr. Cox found that two-thirds of Nova Scotians with heart disease use at least one form of alternative therapy leading to potentially lethal interactions with prescription drugs. For instance, the blood thinner warfarin should not be used in conjunction with high doses of vitamin K, ephedra and ginseng, et cetera.
Dr. Luis Melo, from the University of Saskatchewan, used his CIHR support to discover a protein that is involved in regulating heart attacks. By understanding this protein he hopes to design a safe and efficient gene therapy strategy to protect the heart from damage due to heart attacks.
I would like to talk about Dr. Renée Lyons and Dr. Judy Guernsey who are doing CIHR funded research in Atlantic Canada looking at rural health, women's health and population health, and how to promote health in those areas that do not have huge hospitals. The question is, how do we get people to live more healthily, to not be sick, and how do we keep them well once they have been sick? There has been tremendous research done by Dr. Renée Lyons and Dr. Judy Guernsey.
These are just a few examples of CIHR funded research that are providing much needed hope for those suffering from heart disease or those who might otherwise suffer from heart disease.
I am pleased the Government of Canada created the Canadian Institutes of Health Research. CIHR is providing an integrated, coordinated, problem based and strategic approach to all of the health and disease challenges that face Canadians.
Through the efforts of CIHR and the leadership of its Institute of Circulatory and Respiratory Health, Canadians can be confident that their investments in heart research, both through their tax dollars and their generous support to heart health charities, are being spent in a coordinated and successful manner.
We do need a coordinated national strategy on cancer, on cardiovascular health, and we need one on mental health. This is not a partisan issue; this is a non-partisan issue. Last week I had the opportunity to meet with TEAM Work Cooperative, a group in Halifax doing some tremendous work with mental health consumers. I was at the meeting with the members from Halifax. We discussed their needs and about ways that we could approach government together to make things better.
We all know the cost of cardiovascular disease, mental health challenges and cancers. Research is the key. The Canadian Institutes of Health Research is becoming a world leader in this area and it can be an important part of whatever strategy Canada needs to combat these diseases.